Medicxi launches Alys Pharmaceuticals with $100m funding to develop groundbreaking therapies in immunodermatology. The company aims to address unmet needs ...
Foreign investors are turning to Indian infrastructure-focused mutual funds for long-term wealth growth. Analysts predict growth in this sector, but ...